Clinical Trial Testing Estrogen Receptor Degrader GDC-9545 Enrolls First Participant
News
The first participant has been enrolled in a Phase 2 clinical trial evaluating the safety and efficacy of GDC-9545 in combination with palbociclib as an investigational treatment for postmenopausal women with estrogen receptor ... Read more